Chyke Doubeni of the Perelman School of Medicine commented on an uptick in colorectal cancer diagnoses in young people. “It is unknown whether screening for sporadic cases in a group with such low disease rate can result in a favorable balance of harms and benefits,” he said. “It is therefore imperative that the various hypotheses for increasing colorectal cancer incidence among people younger than 50 be rigorously tested to determine if changing the current screening age in people who are not at increased familial risk represents the most appropriate public health response.”

July 22, 2019 ・ From Newsweek